Mometasone News
FDA Approves ASMANEX (R) TWISTHALER(R) (Mometasone Furoate Inhalation Powder) for the Once Daily Maintenance Treatment of Asthma in Children Ages 4-11
Schering-Plough Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved ASMANEX (R) TWISTHALER (R) 110 mcg (mometasone furoate inhalation powder) for the maintenance treatment of asthma as a...
Azelastine vs. Mometasone: H1 receptor blocker with faster onset of action and higher efficacy
Azelastine hydrochloride (Allergodil®) nasal spray was found to have a faster onset of action than intranasal corticosteroid mometasone furoate in patients with seasonal allergic rhinitis (SAR), also reducing SAR symptoms more...
Researchers' findings from University of Cambridge advance research.
Study 1: Breast cancer resistance protein (BCRP) and p-glycoprotein could be modulated by certain prescribed corticosteroids.
Once-Daily and Twice-Daily Mometasone Formulations Show Similar Efficacy in Persistent Asthmatics: Presented at ATS.
Treatment with mometasone furoate dry powder (MF-DPI) at dosages of 440 mcg once nightly and 220 mcg twice daily produces similar significant decreases in the need for albuterol rescue medication in patients with persistent...
Soaring pollen counts spur worst allergy season in years. April showers bring May flowers, but this year they've also brought a bumper crop of grass, ragweed and early-budding trees that means misery to millions of allergic Americans.
Experts across the country say they are recording the highest pollen counts they've seen in a decade. And while the Southeast usually gets slammed the hardest when it comes to airborne allergens, this season it may be Yankees who...